Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer

DOI Full Paper Access

82

Citations

29

References

2019

Year

Chia‐Chi Hsu, Bin-Chi Liao, Wei‐Yu Liao, Aleksandra Markovets, Daniel Stetson, Kenneth S. Thress, James Chih‐Hsin Yang

Journal of Thoracic Oncology

References

	Year	Citations

Page 1